^
Association details:
| Biomarker: | PALB2 mutation |
|---|---|
| Cancer: | Pancreatic Adenocarcinoma |
| Regimen: | (5-fluorouracil + irinotecan + leucovorin calcium + oxaliplatin) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Preferred Regimens...Only for known BRCA1/2 or PALB2 mutations...FOLFIRINOX or modified FOLFIRINOX…
